Related Experiment Video
Updated: Apr 26, 2026

07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
576
In search of next generation antimalarials
Sankar Chatterjee1, Keiichi Tanabe1, Edward A Nodiff1
1Franklin Research Center, Norristown, PA 19403, USA.
Bioorganic & Medicinal Chemistry Letters
|August 13, 2014
Summary
New compounds show promise for treating all forms of malaria. These potent molecules are effective in animal models without causing toxicity, offering hope for a universal malaria cure.
Area of Science:
- Malariology
- Medicinal Chemistry
- Pharmacology
Background:
- Malaria remains a significant global health challenge, caused by Plasmodium parasites.
- Relapsing and non-relapsing forms of malaria require distinct treatment strategies.
- The need for a single, effective antimalarial drug is critical.
Purpose of the Study:
- To identify novel compounds with broad-spectrum antimalarial activity.
- To evaluate the efficacy and safety of new drug candidates.
- To explore the potential for a single molecule to treat both relapsing and non-relapsing malaria.
Main Methods:
- Synthesis and chemical characterization of compounds 7-10.
- In vivo testing of compound efficacy in animal models of malaria.
- Assessment of compound toxicity in animal models.
Main Results:
- Compounds 7-10 demonstrated significant antimalarial potency.
- No apparent toxicity was observed for compounds 7-10 in animal models.
- The compounds were effective against both relapsing and non-relapsing forms of malaria.
Conclusions:
- Compounds 7-10 represent promising drug candidates for malaria treatment.
- These findings offer hope for a single therapeutic agent effective against diverse malaria forms.
- Further development of these compounds could lead to a universal malaria cure.
Related Concept Videos
Anthelminthic Agents
99
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
99
Antifungal Agents
114
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
114
Antimicrobial Effectiveness
2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Diversity of Protists II
2.3K
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
2.3K
Pharmacogenomics: Identification of New Drug Targets
119
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119

